LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1389 | 1883 | 5445 | 0.3463 | 0.1666 |
MCF7 | GW843682X | 1.11 | uM | LJP6 | 72 | hr | 1389 | 1547 | 5445 | 0.2835 | 0.0527 |
MCF7 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1488 | 5445 | 0.2731 | 0.0338 |
MCF7 | GW843682X | 10 | uM | LJP6 | 72 | hr | 1389 | 1588 | 5445 | 0.2911 | 0.0675 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5118 | 5905 | 0.8669 | 0.8678 |
MCF7 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 4556 | 5905 | 0.7718 | 0.7667 |
MCF7 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 3820 | 5905 | 0.6458 | 0.6201 |
MCF7 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1389 | 2373 | 5905 | 0.4013 | 0.2906 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1646 | 5905 | 0.2786 | 0.0840 |
MCF7 | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1389 | 990 | 5905 | 0.1674 | -0.1512 |
MCF7 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3675 | 5445 | 0.6770 | 0.6408 |
MCF7 | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 3585 | 5445 | 0.6584 | 0.6171 |
MCF7 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 3381 | 5445 | 0.6226 | 0.5710 |
MCF7 | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 1389 | 2672 | 5445 | 0.4902 | 0.3914 |
MCF7 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1909 | 5445 | 0.3509 | 0.1747 |
MCF7 | HG-5-88-01 | 10 | uM | LJP6 | 72 | hr | 1389 | 1247 | 5445 | 0.2291 | -0.0551 |
MCF7 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 6450 | 5445 | 1.1889 | 1.1853 |
MCF7 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 5981 | 5445 | 1.1007 | 1.1010 |
MCF7 | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 5714 | 5445 | 1.0532 | 1.0545 |
MCF7 | HG-6-64-01 | 1.11 | uM | LJP6 | 72 | hr | 1389 | 5483 | 5445 | 1.0109 | 1.0120 |
MCF7 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 3449 | 5445 | 0.6335 | 0.5851 |
MCF7 | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1389 | 896 | 5445 | 0.1651 | -0.1996 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3737 | 5905 | 0.6332 | 0.6068 |
MCF7 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 3990 | 5905 | 0.6742 | 0.6524 |
MCF7 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 3852 | 5905 | 0.6518 | 0.6287 |